These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35642275)

  • 1. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic.
    Bektay MY; Seker Z; Eke HK; Turk HM; Izzettin FV
    J Oncol Pharm Pract; 2023 Jul; 29(5):1178-1186. PubMed ID: 35642275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
    Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
    Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
    Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
    Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Assessment of Different Decision Support Software from the Perspective of Potential Drug-Drug Interactions in Patients with Chronic Kidney Diseases.
    Bektay MY; Buker Cakir A; Gursu M; Kazancioglu R; Izzettin FV
    Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
    Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
    Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
    J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination and comparison of potential drug-drug interactions using three different databases in northern cyprus community pharmacies.
    Alkhalid ZN; Birand N
    Niger J Clin Pract; 2022 Dec; 25(12):2005-2009. PubMed ID: 36537458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.
    Nguyen T; Liu X; Abuhashem W; Bussing R; Winterstein AG
    Pharmacotherapy; 2020 May; 40(5):455-468. PubMed ID: 32107798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.
    Grizzle AJ; Horn J; Collins C; Schneider J; Malone DC; Stottlemyer B; Boyce RD
    J Med Internet Res; 2019 Jan; 21(1):e11182. PubMed ID: 30609981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
    Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
    Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
    Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
    J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expenditure of computer-related worktime using clinical decision support systems in chronic pain therapy.
    Hecht T; Bundscherer AC; Lassen CL; Lindenberg N; Graf BM; Ittner KP; Wiese CH
    BMC Anesthesiol; 2015 Aug; 15():113. PubMed ID: 26231078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
    Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
    BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
    Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
    Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.
    Li L; Baker J; Quirk R; Deidun D; Moran M; Salem AA; Aryal N; Van Dort BA; Zheng WY; Hargreaves A; Doherty P; Hilmer SN; Day RO; Westbrook JI; Baysari MT
    Drug Saf; 2024 Jun; 47(6):557-569. PubMed ID: 38478349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
    Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
    J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential drug-drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study.
    Wondm SA; Tamene FB; Gubae K; Dagnew SB; Worku AA; Belachew EA
    BMJ Open; 2023 Dec; 13(12):e077863. PubMed ID: 38070913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.